Clinical Trials Browser

Phase 2 × Carcinoma, Merkel Cell × relatlimab × Clear all

NCT06151236 2026-02-17

Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

Phase 2 Recruiting

Carcinoma, Merkel Cell